Search details
1.
The variability of diagnosed migraine epidemiology amongst different municipalities in southern Israel.
J Headache Pain
; 24(1): 25, 2023 Mar 13.
Article
in English
| MEDLINE | ID: mdl-36915052
2.
The Clinical and Economic Burden of Tardive Dyskinesia in Israel: Real-World Data Analysis.
J Clin Psychopharmacol
; 42(5): 454-460, 2022.
Article
in English
| MEDLINE | ID: mdl-36018237
3.
Burden of migraine in Brazil: A cross-sectional real-world study.
Headache
; 62(10): 1302-1311, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36426738
4.
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting.
J Headache Pain
; 23(1): 160, 2022 Dec 14.
Article
in English
| MEDLINE | ID: mdl-36517741
5.
Healthcare utilization, costs, and epidemiology of Huntington's disease in Israel.
Clin Park Relat Disord
; 9: 100208, 2023.
Article
in English
| MEDLINE | ID: mdl-37497383
6.
Defining Utility Values for Chorea Health States in Patients with Huntington's Disease.
Adv Ther
; 39(4): 1784-1793, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35195860
7.
Defining utility values for patients with tardive dyskinesia.
Curr Med Res Opin
; 38(3): 401-407, 2022 Mar.
Article
in English
| MEDLINE | ID: mdl-35045768
8.
Budgetary Impact of Bendamustine Ready-to-Dilute Products in Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma to a United States Infusion Facility.
Clinicoecon Outcomes Res
; 13: 201-211, 2021.
Article
in English
| MEDLINE | ID: mdl-33790596
9.
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.
J Med Econ
; 24(1): 835-836, 2021.
Article
in English
| MEDLINE | ID: mdl-34182864
Results
1 -
9
de 9
1
Next >
>>